XML 79 R57.htm IDEA: XBRL DOCUMENT
v3.20.4

Income (Loss) Per Share - Shares Excluded from EPS (Details) - shares shares in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018
Common share equivalents |  |  |
Diluted income (loss) per share |  |  |
Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive | 947 | 531 | 28
Potentially dilutive shares |  |  |
Diluted income (loss) per share |  |  |
Securities excluded from the diluted calculation as their effect would be antidilutive | 923 | 1,689 | 2,474
Convertible Notes - 2023, 2025 and 2027 |  |  |
Diluted income (loss) per share |  |  |
Securities excluded from the diluted calculation as their effect would be antidilutive | 17,753 | 8,618 | 8,618

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Securities excluded from the computation of diluted net loss per share, due to a net loss incurred by the Company during the period, as their effect would be antidilutive. + References No definition available. + Details
Name: | veco_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDueToLossIncurredAmount
Namespace Prefix: | veco_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=veco_CommonStockEquivalentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=veco_PotentiallyDilutiveSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |